Waters Corp. (WAT) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Waters Corp. (WAT) PT, Estimates Raised at Jefferies Post Q2
July 23, 2014 9:00 AM EDTJefferies analyst Brandon Couillard raised his price target on Waters Corp. (NYSE: WAT) to $105.00 (from $98.00) following Q2 results but maintained a Hold rating.
Couillard comments, "Post WAT's 2Q14 print, we are raising our 2014 & 2015 EPS forecasts to $5.32 (from $5.30) and $5.82 (from $5.80), respectively, which imply... More
Waters Corp. (WAT) Acquires MediMass' REIMS Technology
July 22, 2014 9:48 AM EDTWaters Corp. (NYSE: WAT) announced the acquisition of Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology from MediMass Ltd. The REIMS technology represents substantially all of the assets of MediMass and includes patent applications, software, databases and REIMS expertise.
While showing promise across many applications, REIMS technology significantly strengthens Waters technology position within Health Sciences, said Rohit Khanna, Vice-President, Worldwide Marketing and Informatics, Waters Division. This technology acquisition along with our... More



